James Boylan

James Boylan

DirectoratImmunome· In proxies 2023–2025

James Boylan sits on 6 public boards.

Boards1

  • ImmunomeDirector · 1 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. ImmunomePublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +575%
  2. Compass Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Enavate Sciences, Compass Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Graviton BioPublic company
    • Director? – PresentNo stock prices for these years
  5. Zenas BioPharmaPublic company
    • Director? – PresentNo stock prices for these years
  6. CAMP4 TherapeuticsPublic company
    • Director? – 2025No stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?